{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:24:30Z","timestamp":1774441470620,"version":"3.50.1"},"reference-count":76,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,5,30]]},"DOI":"10.18632\/oncotarget.1747","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:40:08Z","timestamp":1442360408000},"page":"3039-3054","source":"Crossref","is-referenced-by-count":84,"title":["Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: <i>in vitro<\/i> and <i>in vivo<\/i> anti-tumor activity"],"prefix":"10.18632","volume":"5","author":[{"given":"Lavinia","family":"Raimondi","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Di Martino","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Altomare","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Leotta","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Caracciolo","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Gull\u00e0","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Milan, Hematology1, IRCCS Policlinico Foundation, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Taverna","sequence":"additional","affiliation":[{"name":"Department of Pathology and Forensic and Medical Biotechnology, Section of Biology and Genetics, University of Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"D\u2019Aquila","sequence":"additional","affiliation":[{"name":"Department of Biology, Ecology and Earth Science (DiBEST),University of Calabria, Arcavacata di Rende, Cosenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Alessandro","sequence":"additional","affiliation":[{"name":"Department of Pathology and Forensic and Medical Biotechnology, Section of Biology and Genetics, University of Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[{"name":"Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierosandro","family":"Tagliaferri","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"},{"name":"Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2014,3,14]]},"reference":[{"issue":"11","key":"1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Anderson","year":"2011","journal-title":"N Engl J Med"},{"issue":"13","key":"2","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/1078-0432.CCR-12-1881","article-title":"New strategies in the treatment of multiple myeloma","volume":"19","author":"Anderson","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3","first-page":"707","article-title":"A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells","volume":"25","author":"Tassone","journal-title":"Leukemia"},{"issue":"2","key":"4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood-2005-01-0373","article-title":"A clinically relevant SCID-hu in vivo model of human multiple myeloma","volume":"106","author":"Munshi","year":"2005","journal-title":"Blood"},{"issue":"7","key":"5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2174\/156800912802429292","article-title":"Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma","volume":"12","author":"Tagliaferri","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"7","key":"6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/156800912802429300","article-title":"Molecular targets for the treatment of multiple myeloma","volume":"12","author":"Caraglia","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"Suppl 1","key":"7","first-page":"S95","article-title":"Emerging pathways as individualized therapeutic target of multiple myeloma","volume":"13","author":"Caraglia","year":"2013","journal-title":"Expert opinion on biological therapy"},{"issue":"3","key":"8","first-page":"325","article-title":"Angiogenesis and multiple myeloma","volume":"4","author":"Bonomini","journal-title":"Cancer Microenviron"},{"key":"9","first-page":"281261","article-title":"Targeting the tumor microenvironment: focus on angiogenesis","author":"Podar","year":"2012","journal-title":"J Oncol"},{"issue":"3","key":"10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.18632\/oncotarget.234","article-title":"Recent advances in anti-angiogenic therapy of cancer","volume":"2","author":"Shevde","year":"2011","journal-title":"Oncotarget"},{"issue":"11","key":"11","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.ejca.2006.02.017","article-title":"Angiogenesis in multiple myeloma","volume":"42","author":"Sezer","year":"2006","journal-title":"Eur J Cancer"},{"issue":"7","key":"12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2174\/156800912802429346","article-title":"Antiangiogenic therapeutic approaches in multiple myeloma","volume":"12","author":"Vacca","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0070-2153(06)76007-0","article-title":"Regulation of angiogenesis by hypoxia and hypoxia-inducible factors","volume":"76","author":"Simon","year":"2006","journal-title":"Curr Top Dev Biol"},{"issue":"5","key":"14","first-page":"776","article-title":"Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells","volume":"95","author":"Zannettino","journal-title":"Haematologica"},{"issue":"10","key":"15","first-page":"1533","article-title":"The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma","volume":"25","author":"Zannettino","journal-title":"Leukemia"},{"issue":"10","key":"16","first-page":"RA175","article-title":"Recent advances in tumor hypoxia: tumor progression, molecular mechanisms, and therapeutic implications","volume":"13","author":"Chen","year":"2007","journal-title":"Med Sci Monit"},{"issue":"8","key":"17","first-page":"1697","article-title":"Hypoxia-inducible factor (HIF)-1alpha suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction","volume":"27","author":"Neri","journal-title":"Leukemia"},{"key":"18","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1371\/journal.pone.0000116","article-title":"MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia","volume":"1","author":"Zhang","year":"2006","journal-title":"PLoS One"},{"issue":"2","key":"19","first-page":"a006643","article-title":"miRNAs as modulators of angiogenesis","volume":"3","author":"Sessa","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Croce","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/gcc.20660","article-title":"Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles","volume":"48","author":"Neri","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"issue":"25","key":"22","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1182\/blood-2009-08-237495","article-title":"Identification of microRNA expression patterns and definition of a microRNA\/mRNA regulatory network in distinct molecular groups of multiple myeloma","volume":"114","author":"Neri","year":"2009","journal-title":"Blood"},{"issue":"7","key":"23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2174\/156800912802429274","article-title":"MicroRNAs in the pathobiology of multiple myeloma","volume":"12","author":"Neri","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/cncr.26297","article-title":"Deregulated microRNAs in multiple myeloma","volume":"118","author":"Vartholomatos","year":"2012","journal-title":"Cancer"},{"issue":"20","key":"25","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4161\/cc.26087","article-title":"microRNA-mediated regulation of the tumor microenvironment","volume":"12","author":"Werb","year":"2013","journal-title":"Cell Cycle"},{"issue":"1","key":"26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18632\/oncotarget.424","article-title":"microRNA-1\/133a and microRNA-206\/133b clusters: dysregulation and functional roles in human cancers","volume":"3","author":"Seki","year":"2012","journal-title":"Oncotarget"},{"issue":"46","key":"27","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1038\/sj.onc.1209910","article-title":"MicroRNAs and chromosomal abnormalities in cancer cells","volume":"25","author":"Croce","year":"2006","journal-title":"Oncogene"},{"issue":"35","key":"28","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0806202105","article-title":"MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis","volume":"105","author":"Aqeilan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/156800912802429355","article-title":"Promises and challenges of MicroRNA-based treatment of multiple myeloma","volume":"12","author":"Tassone","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"22","key":"30","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1158\/1078-0432.CCR-12-1708","article-title":"Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence","volume":"18","author":"Shammas","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"10","key":"31","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.18632\/oncotarget.675","article-title":"DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma","volume":"3","author":"Tassone","year":"2012","journal-title":"Oncotarget"},{"key":"32","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1038\/cddis.2012.175","article-title":"miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1","volume":"3","author":"Neri","year":"2012","journal-title":"Cell Death Dis"},{"issue":"7","key":"33","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jcp.24306","article-title":"miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease","volume":"228","author":"Tassone","year":"2013","journal-title":"J Cell Physiol"},{"issue":"2","key":"34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.18632\/oncotarget.820","article-title":"In vitro and in vivo anti-tumor activity of miR-221\/222 inhibitors in multiple myeloma","volume":"4","author":"Tassone","year":"2013","journal-title":"Oncotarget"},{"issue":"Suppl 1","key":"35","first-page":"S125","article-title":"Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma","volume":"13","author":"Tassone","year":"2013","journal-title":"Expert Opin Biol Ther"},{"issue":"23","key":"36","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.4161\/cc.26585","article-title":"miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells","volume":"12","author":"Tassone","year":"2013","journal-title":"Cell Cycle"},{"issue":"8","key":"37","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1078-0432.CCR-12-3325","article-title":"Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth","volume":"19","author":"Tassone","year":"2013","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"4","key":"38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.cdd.4402310","article-title":"A microRNA component of the hypoxic response","volume":"15","author":"Ivan","year":"2008","journal-title":"Cell Death Differ"},{"issue":"5","key":"39","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/MCB.01395-06","article-title":"A microRNA signature of hypoxia","volume":"27","author":"Ivan","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"6","key":"40","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4161\/cc.9.6.11006","article-title":"MicroRNA-210: a unique and pleiotropic hypoxamir","volume":"9","author":"Loscalzo","year":"2010","journal-title":"Cell Cycle"},{"issue":"227","key":"41","article-title":"Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion","volume":"9","author":"Beckebaum","journal-title":"Mol Cancer"},{"issue":"7","key":"42","first-page":"8449","article-title":"Flexible and Versatile as a Chameleon-Sophisticated Functions of microRNA-199a","volume":"13","author":"Chan","journal-title":"Int J Mol Sci"},{"issue":"2","key":"43","first-page":"437","article-title":"MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes","volume":"225","author":"Jing","journal-title":"J Cell Physiol"},{"issue":"16","key":"44","first-page":"3213","article-title":"AKT-ing via microRNA","volume":"9","author":"Abdellatif","year":"2010","journal-title":"Cell Cycle"},{"issue":"7","key":"45","first-page":"1054","article-title":"An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p","volume":"22","author":"Abdellatif","journal-title":"Cell Signal"},{"issue":"31","key":"46","first-page":"3404","article-title":"Methylation of an intronic region regulates miR-199a in testicular tumor malignancy","volume":"30","author":"Chan","journal-title":"Oncogene"},{"issue":"3","key":"47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4161\/cc.8.3.7526","article-title":"How epigenetics can explain human metastasis: a new role for microRNAs","volume":"8","author":"Esteller","year":"2009","journal-title":"Cell Cycle"},{"issue":"8","key":"48","first-page":"800","article-title":"Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood","volume":"85","author":"Giustolisi","year":"2000","journal-title":"Haematologica"},{"issue":"4","key":"49","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2004-07-2909","article-title":"The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications","volume":"105","author":"Anderson","year":"2005","journal-title":"Blood"},{"issue":"1","key":"50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia--a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-8794-2-15","article-title":"Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis","volume":"2","author":"Hong","year":"2009","journal-title":"BMC Med Genomics"},{"issue":"11","key":"52","first-page":"4141","article-title":"Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis","volume":"120","author":"Ramakrishnan","journal-title":"J Clin Invest"},{"issue":"1","key":"53","first-page":"242","article-title":"miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells","volume":"224","author":"Russo","journal-title":"J Cell Physiol"},{"issue":"1","key":"54","first-page":"237","article-title":"Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma","volume":"62","author":"Feng","journal-title":"Cell Biochem Biophys"},{"issue":"7","key":"55","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCRESAHA.108.193102","article-title":"Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes","volume":"104","author":"Abdellatif","year":"2009","journal-title":"Circ Res"},{"issue":"3","key":"56","first-page":"629","article-title":"Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling","volume":"24","author":"San Miguel","journal-title":"Leukemia"},{"issue":"10","key":"57","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.18632\/oncotarget.628","article-title":"Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer","volume":"3","author":"Menssen","year":"2012","journal-title":"Oncotarget"},{"issue":"8","key":"58","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2003-06-1883","article-title":"Do human myeloma cells directly produce basic FGF?","volume":"102","author":"Giuliani","year":"2003","journal-title":"Blood"},{"issue":"13","key":"59","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1182\/blood-2007-02-074617","article-title":"The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis","volume":"110","author":"Neri","year":"2007","journal-title":"Blood"},{"issue":"1","key":"60","first-page":"76","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"1","author":"Vacca","journal-title":"Am J Blood Res"},{"issue":"2","key":"61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.leu.2404067","article-title":"Bone marrow angiogenesis in multiple myeloma","volume":"20","author":"Ribatti","year":"2006","journal-title":"Leukemia"},{"issue":"10","key":"62","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.4161\/cbt.5.10.3162","article-title":"Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines","volume":"5","author":"Gao","year":"2006","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"63","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.18632\/oncotarget.1426","article-title":"Chemokines in tumor progression and metastasis","volume":"4","author":"Lesniak","year":"2013","journal-title":"Oncotarget"},{"issue":"8","key":"64","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1128\/MCB.21.8.2906-2917.2001","article-title":"Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development","volume":"21","author":"Pawson","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"24","key":"65","first-page":"5782","article-title":"Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features","volume":"119","author":"Carrasco","journal-title":"Blood"},{"issue":"3","key":"66","first-page":"305","article-title":"The role of epithelial-mesenchymal transition in cancer pathology","volume":"39","author":"Ballabio","year":"2007","journal-title":"Pathology"},{"issue":"17","key":"67","doi-asserted-by":"crossref","first-page":"8319","DOI":"10.1158\/0008-5472.CAN-06-0410","article-title":"Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis","volume":"66","author":"Rajasekaran","year":"2006","journal-title":"Cancer Res"},{"issue":"12","key":"68","first-page":"3503","article-title":"Hypoxia-induced snail expression through transcriptional regulation by HIF-1alpha in pancreatic cancer cells","volume":"58","author":"Qiu","journal-title":"Dig Dis Sci"},{"issue":"4","key":"69","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcp.24176","article-title":"AKT as locus of cancer multidrug resistance and fragility","volume":"228","author":"Radisavljevic","journal-title":"J Cell Physiol"},{"issue":"7","key":"70","doi-asserted-by":"crossref","first-page":"530","DOI":"10.18632\/oncotarget.188","article-title":"Targeting the PI3K\/Akt\/mTOR pathway--beyond rapalogs","volume":"1","author":"Tabernero","year":"2010","journal-title":"Oncotarget"},{"issue":"1","key":"71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/nar\/gkn920","article-title":"Twist-1 regulates the miR-199a\/214 cluster during development","volume":"37","author":"Uney","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"72","first-page":"640","article-title":"Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication","volume":"98","author":"Gutierrez","journal-title":"Haematologica"},{"issue":"5","key":"73","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood.V97.5.1172","article-title":"Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia","volume":"97","author":"Sasaki","year":"2001","journal-title":"Blood"},{"issue":"12","key":"74","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/BF00969002","article-title":"H1(0) and H3. 3B mRNA levels in developing rat brain","volume":"19","author":"Di Liegro","year":"1994","journal-title":"Neurochem Res"},{"issue":"1","key":"75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00711637","article-title":"Qualitative differences in nuclear proteins correlate with neuronal terminal differentiation","volume":"12","author":"Di Liegro","year":"1992","journal-title":"Cell Mol Neurobiol"},{"issue":"22","key":"76","first-page":"6260","article-title":"Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence","volume":"18","author":"Shammas","journal-title":"Clin Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.1747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T14:36:50Z","timestamp":1594823810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.1747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,14]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,5,30]]}},"alternative-id":["1747","24839982"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.1747","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,14]]}}}